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ABSTRACT
Type II DNA topoisomerases (topos) are essential
and ubiquitous enzymes that perform important
intracellular roles in chromosome condensation
and segregation, and in regulating DNA supercoil-
ing. Eukaryotic topo II, a type II topoisomerase, is
a homodimeric enzyme that solves topological
entanglement problems by using the energy from
ATP hydrolysis to pass one segment of DNA through
another by way of a reversible, enzyme-bridged
double-stranded break. This DNA break is linked
to the protein by a phosphodiester bond between
the active site tyrosine of each subunit and back-
bone phosphate of DNA. The opening and closing
of the DNA gate, a critical step for strand passage
during the catalytic cycle, is coupled to this enzy-
matic cleavage/religation of the backbone. This
reversible DNA cleavage reaction is the target of a
number of anticancer drugs, which can elicit DNA
damage by affecting the cleavage/religation equilib-
rium. Because of its clinical importance, many
studies have sought to determine the manner in
which topo II interacts with DNA. Here we highlight
recent single-molecule fluorescence resonance
energy transfer and crystallographic studies that
have provided new insight into the dynamics and
structure of the topo II DNA gate.
INTRODUCTION
DNA topoisomerases (topos) are molecular machines
that regulate the topology of DNA in the cell by allowing
DNA strands or double helices to pass through one
another. They accomplish this feat via a mechanism invol-
ving the breakage and reformation of phosphodiester
bonds in the DNA backbone (1–7). Transesteriﬁcation
between an enzyme tyrosyl residue and a DNA phosphate
group severs the DNA backbone and results in a covalent
enzyme–DNA intermediate; this reaction can be readily
reversed to reseal the DNA break. Cells require this activ-
ity to resolve topological problems that arise during DNA
metabolism because of the double helical nature of DNA
and the manner in which DNA is packaged. For such
processes as replication or transcription, the helices must
separate to allow access to the information stored in the
DNA. However, because DNA exists either as circular
rings or is associated with proteins, the DNA double-
helix supercoils when unwound by cellular machinery.
Not only must topos remove these supercoils, they must
also decatenate completely replicated DNA prior to cell
division, and they play key roles in the maintenance of
chromosome structure and genome stability. In the fol-
lowing sections, we describe the architecture of topo II
and the proposed mechanism of action that allows it to
carry out such DNA transactions.
Architecture of topoII
Topoisomerases are classiﬁed into two main families, type
I and type II, based on whether they break one strand of
DNA at a time (type I) or create a double-stranded break
in the DNA (type II) (8,9). Here we focus on eukaryotic
type II topos, whose dimeric architecture enables them
to create such double-stranded breaks. Eukaryotic topo
II is composed of three principal domains (ATPase, B0,
A0) that are linked by ﬂexible hinge regions (Figure 1)
(10–12). Nucleotide binding triggers dimerization of the
N-terminal ATPase domains, whose opening and closing
is regulated by ATP hydrolysis and product release
(10,13,14). The ATPase domain is followed by the central
core region, which is composed of the B0 domain and the
N-terminal portion of A0. The A0 domain contains the
active site tyrosyl residue required for catalysis and is
thus referred to as the DNA breakage and rejoining
domain. Topo II has a hydrophilic C-terminus (not pic-
tured in Figure 1) that immediately follows the A0 domain,
and its sequence is only somewhat similar for closely
related species. The C-terminal tail is dispensable for
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serves several important intracellular roles, such as nuclear
localization and interaction with other proteins (18–20).
Over the past two decades, several structures of type II
topos have been determined (8,9,21–23). These structures
have enabled a deeper understanding of the topo II cata-
lytic mechanism. For eukaryotic type II topos, structures
have been determined for N- and C-terminal fragments
of Saccharomyces cerevisiae topo II as well as the
ATPase domain of human topo IIa. Although a structure
has not been solved for a full-length type II topoisomer-
ase, the available structures provide a near-complete pic-
ture of the architecture of topo II.
One such structure includes the yeast ATPase domain
bound to AMPPNP (24). The ATPase region forms a
heart-shaped dimer upon nucleotide binding and folds
into two discrete domains: the N-terminal region bears
the characteristic GHKL ATP-binding fold, while the
C-terminal region comprises the transducer domain. The
GHKL superfamily is named for its founding members
DNA gyrase, Hsp90, histidine kinase and Mut L, and it
forms the primary dimer interface of the ATPase region.
The C-terminal transducer domain is situated below the
ATP-binding fold and is thought to transduce ATP bind-
ing and hydrolysis signals to downstream regions of the
enzyme, thus coordinating DNA cleavage/religation with
DNA transport. Structural support for this proposed
transducing role is evidenced by structures of human
topo IIa, which were solved with the enzyme in diﬀerent
nucleotide-bound states, either to AMPPNP or ADP (25).
Relative to the AMPPNP-bound form, topo II undergoes
structural arrangements in the ADP-bound form in which
the transducer domain swings out to form a more open
and mobile cavity at the base of the structure.
In addition to the structures described for the ATPase
domain, structures of a large yeast fragment containing
the B0 and A0 domains forming the cleavage core have
been solved (22,26,27). The core region of topo II also
forms a heart-shaped dimer with a central cavity more
than large enough to accommodate duplex DNA, which
is thought to exit at the C-terminal dimer interface
(C-gate) of the enzyme. The N-terminal portion of the
topo II cleavage/core region contains what has been
termed the TOPRIM (TOpoisomerase/PRIMase)
domain. This region contains the conserved acidic residues
believed to promote formation of the topo II/DNA phos-
phodiester linkage by coordinating Mg
2+, which is essen-
tial for DNA cleavage. The core of topo II also includes a
winged-helix domain (WHD) that contains the active site
tyrosyl residue essential for DNA cleavage, and a ‘tower’
domain, which was found to act as a supporting element
for DNA (22). The recently determined topo II/DNA
structure (described in more detail in succeeding sections)
also provides support to previous biochemical evidence
that the C-terminal domain (C-gate) of topo II opens to
allow expulsion of the transported DNA segment (28).
Structures from both N- and C-terminal fragments of
topo II have been combined to illustrate a more complete
picture of the enzyme, shown in Figure 1. This structure
includes the ATPase domain and the B0 and A0 fragments
of the yeast enzyme. A detailed view of topo II’s structural
subdomains can be found in a recent review (23).
Two-gate model forDNA transport
Structural and biochemical evidence have led to the
two-gate model for topo II-mediated DNA transport
(Figure 2) (22,26,28–30). In this model, topo II utilizes
the energy from ATP to transport one intact DNA
duplex through an enzyme-mediated 4-bp staggered
double-stranded break in a second duplex. In the ﬁrst
step of the reaction, the N-terminal ATPase domains
(N-gate) are separated, allowing topo II to bind a DNA
duplex within the binding/cleavage core. This DNA has
been termed the gate or ‘G-segment’ because it serves as a
gate through which another strand must pass. ATP bind-
ing to the N-terminal GHKL domains triggers their
dimerization and capture of a second DNA duplex.
Closure of this N-gate induces a succession of conforma-
tional changes that promotes the cleavage and opening
of the G-segment, followed by transport of the captured
DNA (T-segment DNA) through the break. The
T-segment then exits through the opened C-terminal
dimerization interface (C-gate), and the DNA gate closes
to allow G-segment religation.
Until recently, topo II-mediated G-segment breaks had
only been monitored by trapping cleaved DNA with a
potent denaturant and analyzing the resultant fragments
with techniques such as gel electrophoresis. Because this
method is indirect and could possibly perturb the DNA
Figure 1. Structure of yeast topo II. Structures of Saccharomyces
cerevisiae topo II (PDB 1PVG and 1BGW) were computationally
docked together to illustrate a possible representation of the enzyme.
ATPase domains, shown in blue, form the N-gate. The central B0-sub-
fragment forms the DNA gate (green). The C-terminal A0 portion (red)
encloses a hole large enough to accommodate T-segment DNA, which
is thought to exit through the C-gate.
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topo II DNA gate. Therefore, single-molecule ﬂuorescence
resonance energy transfer (FRET) was developed to
directly examine the topo II conformational changes
accompanying these G-segment breaks (31). Furthermore,
new crystallographic work has unlocked important struc-
tural details about the topo II/DNA complex (22).
This new information is discussed below in terms of the
two-gate model.
TOPO-II DNA GATE STUDIES
Fluorescence resonance energy transfer (FRET)
FRET has been used extensively for estimating the spatial
separation between ﬂuorophores (32). The relationship
between FRET eﬃciency and distance is described by:
E ¼
R6
o
R6
o þ r6 1
where E is the energy transfer eﬃciency, Ro is the distance
for 50% energy transfer (Fo ¨ rster distance), and r is the
distance between donor and acceptor ﬂuorophore
pairs (33). Because the energy transfer eﬃciency of two
ﬂuorophores depends on the distance between them, this
technique is a powerful tool for measuring the internal
distance changes of molecules. In the work to be dis-
cussed, a nucleic-acid substrate labeled with a FRET
pair was used to examine the conformational changes
occurring in the topo II DNA gating reaction.
Fluorescent topoII substrate
DNA cleavage, aperture, closure and religation are critical
steps in the topo II reaction cycle that are targeted by a
host of clinically important anticancer drugs which take
advantage of the fact that topo II creates breaks in DNA.
Smiley et al. used FRET in an eﬀort to directly study the
topo II movements associated with forming these DNA
breaks (31). A substrate was created (Figure 3A) that
positioned a pair of ﬂuorophores on either side of a
Drosophila melanogaster topo II cleavage site (34,35).
Figure 3. (A) Design of the ﬂuorescent DNA substrate. A 28-bp oligo-
nucleotide-based DNA substrate was synthesized with a known
Drosophila topo II cleavage site (indicated by arrows) ﬂanked by a
FRET pair, Alexa Fluor 488 (green) and Alexa Fluor 555 (magenta),
separated by  1.5 turns on complementary strands. Another substrate
was created with Alexa Fluor 488 at the same position, but with Alexa
Fluor 546 linked to a diﬀerent thymidine (red). (B) A schematic dia-
gram of the topo II/DNA complex illustrating the use of FRET in
monitoring the opening and closing of the DNA gate. The donor
and acceptor ﬂuorophores on the DNA are marked in green and
magenta, respectively. ATP is indicated by the yellow circles. (C)
Decrease in FRET eﬃciency is reversible. The FRET eﬃciency of
DNA (blue bar) decreases upon addition of topo II when Mg
2+/ATP
is present (red bar). When the reaction is reversed with EDTA/NaCl
treatment (green bar), the FRET eﬃciency is restored.
Figure 2. Catalytic cycle of topo II, adapted from Dong and Berger
(22). Topo II binds to a DNA duplex, the G-segment (red bar), causing
signiﬁcant DNA bending. ATP (yellow circle) binds to the N-terminal
domains, promoting the capture of a second DNA duplex, the T-seg-
ment (green bar) and dimerization of the ATPase domains (N-gate).
Closure of the N-gate stimulates cleavage of G-segment DNA, coupled
with opening of the DNA gate to allow passage of the T-segment
through this double-stranded break. The G-segment is religated and
the T-segment exits after opening of the C-gate.
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sively in experiments to investigate DNA binding and
cleavage by topo II (36–38). While topo II has a modest
sequence preference in the cleavage reaction, use of this
oligonucleotide substrate with a strongly preferred
sequence will result in cleavage at a single speciﬁc site.
Substrates 28bp in length were used because earlier
footprinting experiments demonstrated that the contact
between the enzyme and DNA was limited to  25bp
(39,40). Alexa Fluor 488 and Alexa Fluor 555 (or Alexa
Fluor 546) were chosen as the FRET pair, and were placed
such that they undergo eﬃcient FRET when the substrate
is intact, but their FRET eﬃciency decreases when
the DNA gate opens (Figure 3B). Each partner of the
FRET pair was conjugated to the thymidine ring at the
C5 position and separated from the double helix by a ﬂex-
ible linker arm.
The Fo ¨ rster distance (Ro) for Alexa Fluor 488 and
Alexa Fluor 555 is 70A ˚ , which indicates that the FRET
eﬃciency is 50% when they are 70A ˚ apart. For the Alexa
Fluor 488 and Alexa Fluor 546 pair, Ro is 64A ˚ . Given that
the distance between the ﬂuorophores in the intact sub-
strate is predicted to be  54A ˚ (for Alexa Fluor 488/Alexa
Fluor 555) or  57A ˚ (for Alexa Fluor 488/Alexa Fluor
546) based on typical B-helical DNA geometry, FRET
between these pairs of ﬂuorophores is eﬃcient when the
DNA gate is closed. In the open state, the severed DNA
ends are predicted to move apart at least as far as the
diameter of B-DNA, or  20A ˚ (27). The ﬂuorophore dis-
tances in either the open or closed DNA gate are similar
to Ro, and therefore changes in distance associated with
the predicted gate opening should result in a relatively
large change in FRET.
Ensemble experiments
Ensemble experiments with the ﬂuorescent substrate
demonstrate that there is a large decrease in FRET upon
addition of Mg
2+ (10mM)/ATP (1mM). This decrease in
FRET was attributed to an increase in distance between
the ﬂuorophore pair as the DNA gate opens to physically
separate the ﬂuorophores. The FRET eﬃciency is sensitive
to temperature; if the normal reaction temperature (308C)
is signiﬁcantly lowered, only a small decrease in FRET
occurs, suggesting that a majority of the DNA gates are
in the closed state at low temperatures. Furthermore, the
FRET decrease can be reversed with the addition of high
salt and EDTA (Figure 3C), which is known to reverse
topoisomerase cleavage reactions.
Sensitivity to temperature and EDTA/salt reversal
strongly suggests that the observed decrease in FRET is
due to topo II DNA gate opening. However, the possibil-
ity exists that FRET decreases because of relative orien-
tation changes between the FRET pair. In calculating Ro,
a dynamic average of all possible orientations between the
donor and acceptor was assumed (41). To determine
whether this assumption was valid, ﬂuorescence polariza-
tion was measured. Polarization values were consistent
with signiﬁcant rotational freedom in the donor and
acceptor pairs, and were unchanged upon addition of
Mg
2+/ATP. This suggests that changes and/or restrictions
in the relative orientations of the donor and acceptor are
not responsible for the observed FRET decrease. Taken in
combination with several other controls, these lines of evi-
dence are consistent with the measured FRET changes
being sensitive to the opening and closing of the topo II
DNA gate. To further probe the DNA gates of individual
topoisomerase enzymes, the ﬂuorescent substrate was used
for single-molecule FRET.
Monitoring the topo II DNA gate with single-molecule
FRET
Single-molecule FRET (smFRET) experiments are power-
ful tools for studying enzyme dynamics and mechanisms
(42,43). Examination of the reaction trajectories (time
dependence of ﬂuorescence) of single molecules can pro-
vide mechanistic information that is not readily available
from ensemble experiments. Therefore, smFRET was used
to investigate the topo II DNA gate dynamics.
As shown from ensemble experiments, the oligonucleo-
tide substrate with an attached FRET pair was useful
for examining the topoisomerase reaction at the DNA
gate. For the smFRET experiments, the ﬂuorescent
DNA was tagged with biotin at one end and bound to a
NeutrAvidin-coated glass slide (Figure 4A). Single mole-
cules of DNA were identiﬁed with total internal reﬂection
ﬂuorescence (TIRF) microscopy, and their behavior was
observed in the presence of topo II, Mg
2+ and ATP. Time
trajectories of the individual molecules were monitored,
and their ﬂuorescence intensity ﬂuctuated between two
distinct states in the presence of 50nM Drosophila topo
II and the cofactors Mg
2+/ATP. The ﬂuctuation between
the two ﬂuorescent states was dependent on the presence
of both ATP and Mg
2+, although Mg
2+ alone could sup-
port occasional gate opening. The critical dependence of
the FRET ﬂuctuation on Mg
2+/ATP is not due to enzyme
binding and dissociation events, because experimental evi-
dence from ﬁlter-binding assays indicates that the absence
of Mg
2+/ATP does not signiﬁcantly aﬀect either the
aﬃnity or speciﬁcity of topo II binding to DNA (44).
Furthermore, our unpublished results show that topo II
remains bound to the ﬂuorescent DNA substrate even
upon extensive washing of the slide or addition of external
DNA. Therefore, the dependence on Mg
2+/ATP is con-
sistent with the FRET ﬂuctuation corresponding to DNA
gate opening and closing. We also examined gate move-
ment in the presence of AMPPNP, which will support one
round of topo II-mediated DNA strand passage (45).
When AMPPNP was substituted for ATP, the single
molecules did not ﬂuctuate between two distinct states,
which provides further evidence that ATP hydrolysis is
required for the gate opening/closing transition.
The high FRET state corresponds to the closed DNA
gate, while the low FRET state corresponds to the opened
DNA gate. The transition between the open and closed
states can be represented as:
Closed state ðhigh FRETÞ         !            
kopen
kclose
Open state ðlow FRETÞ
2
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topo II-mediated opening and closing reactions at the
DNA gate, respectively. The distribution of reaction life-
times, , for a one-step reaction between high- and low-
FRET states is given by the relationship (46):
N
Ntotal
¼ k expð kÞ 3
where N is the number of events with a lifetime , Ntotal is
the total number of events, and k is the ensemble average
ﬁrst-order rate constant [kopen or kclose as deﬁned by
Equation (2)]. A plot of the fraction of single molecules
with a lifetime , N/Ntotal, versus  follows an exponential
decay (Figure 4B) from which the ensemble average rate
constants can be determined. A single exponential ﬁts the
lifetime decay curves, denoting that the data are consistent
with a transition between the closed and open states
[Equation (2)].
From the lifetime decay curves, rate constants for both
DNA gate opening and closing were found to be in the
range of 1–2s
 1. This result is consistent with rate con-
stants for the overall topo II strand passage reaction,
which are also in the range of 1–3s
 1 when measured
with either biochemical or biophysical methods
(45,47,48). Surprisingly, the apparent equilibrium con-
stant is close to one since rate constants for DNA gate
opening and closing are similar. This suggests that under
the conditions tested, the DNA gate spends about half its
time in the open state, and half its time in the closed state,
thus equally populating both states during steady-state
ATP hydrolysis. Additional experiments show that topo
II can equally populate both states even with a substrate
38bp in length, suggesting that at least in the range of
28–38bp, the rate constants for gate opening and closing
do not critically depend on the length of DNA. The
ensemble and single-molecule FRET experiments have
provided direct measurements of the topo II DNA gate
dynamics in the absence of a denaturant. The cleavage/
religation equilibrium, a process related to gate opening/
closing, has previously been investigated through the use
of a denaturant to trap the reaction intermediates. Under
these conditions, the equilibrium clearly favors the reli-
gated state (34). This has led to the assumption that
only a small proportion of topo II/DNA complexes have
opened DNA gates at any given time. The topo II DNA
gate equilibrium may be changed by speciﬁc compounds
(many of which comprise clinically important anticancer
drugs) that promote the cleaved DNA state and therefore
may possibly favor the opened DNA gate (49,50). The
smFRET results, however, are not necessarily at odds
with experiments using a protein denaturant. Denaturing
topo II to trap the cleaved DNA could alter the DNA gate
opening/closing equilibrium to selectively favor the
closed state and/or speciﬁcally capture particular inter-
mediates along the kinetic pathway of gate opening/clos-
ing. Furthermore, support that the FRET results provide
information regarding DNA gate dynamics comes from
estimates of the distance change at the DNA gate.
Figure 4. (A) Schematic representation of the method of immobilizing and visualizing single DNA molecules. Single DNA molecules are attached to
a glass slide using biotin/NeutrAvidin and are separated from the surface via linker arms shown in red, purple and blue. The single DNA molecules
were excited using prism-based total internal reﬂection ﬂuorescence microscopy (TIRF) to create an evanescent ﬁeld above the surface of the slide.
(B) Fraction of single molecules with a lifetime , N/Ntotal, as a function of lifetime. These plots were generated from the reaction trajectories
(time dependence of FRET) of DNA with Alexa Fluor 488/Alexa Fluor 555 in the presence of 50nM Drosophila topo II and Mg
2+/ATP. The solid
lines are weighted non-linear least square ﬁts to Equation (3), from which the ensemble average rate constants can be obtained: kopen from A and
kclose from B.
716 Nucleic Acids Research, 2009, Vol. 37,No. 3Ensemble and single molecule methods are in reasonable
agreement, with both suggesting that the DNA gate can
open  21–23A ˚ , which is large enough to accommodate
passage of a duplex segment.
Comparison of smFRET substrate withtopo II/DNA
structure
Dong and Berger determined the crystal structure of the
DNA binding and cleavage core fragment of S. cerevisiae
topo II bound to a doubly nicked 34-bp oligonucleotide
DNA duplex (22). The duplex was found to bind in the
previously predicted DNA-binding site (26,51), located in
the N-terminal portion of the A0 domain within a deep,
positively charged semicircular groove. Approximately
26bp of the duplex are in direct contact with topo II,
although the enzyme makes little speciﬁc contact with
the nucleotide bases.
The most striking feature of this complex is the dra-
matic degree to which topo II alters the DNA structure.
Each subunit of topo II induces a sharp 758 bend in the
DNA backbone, resulting in a global 1508 bend. This bend
is induced by an isoleucine (Ile 833) residue located on a
b-hairpin near the DNA-binding groove. The highly con-
served Ile residue intercalates between two DNA basepairs
eight nucleotides from the scissile phosphate, thus deform-
ing the DNA minor groove by signiﬁcantly widening it.
This locally induced distortion causes DNA to assume
an altered U-like structure, such that the central  12bp
(bottom of the ‘U’) remain virtually straight (Figure 5A).
The DNA at the base of the ‘U’ adopts an A-form con-
formation, while the duplex region that bends upward as a
result of Ile intercalation (the arms of the ‘U’) remains
B-form. The bent 34-bp DNA substrate packs to form a
68-bp DNA minicircle in the crystal lattice. While the bent
DNA conformation could be a rare intermediate selected
by favorable crystal packing, our previous and new FRET
results discussed below suggest that topo II also bends
DNA in solution.
In light of the new topo II/DNA structure, it is useful to
compare the position of the ﬂuorophores in the enzyme-
free ﬂuorescent substrate to their analogous positions
within the topo II/DNA complex. Because topo II bends
Figure 5. (A) Left panel. Topo II dramatically reshapes DNA. This image depicts the topo II-induced ‘U’-shaped DNA from the topo II/DNA
complex (PDB 2RGR) (22). Black arrows indicate the sites of Ile intercalation. Right panel. Top down view of DNA from the topo II/DNA
complex. The position of Alexa Fluor 488 (green star) and Alexa Fluor 555 (magenta star) are shown in their respective locations upon topo II
bending DNA (linker arm length scaled approximately). The ﬂuorophores are now on opposite sides of the DNA helix. (B) Upper panel. Initial
ﬂuorescent DNA substrate. The 28-bp substrate used in initial FRET studies is shown for comparison with the alternate substrate. The cleavage site
is ﬂanked by the FRET pair, Alexa Fluor 488 (green star) and Alexa Fluor 555 (magenta star), on complementary strands. The gray diamonds
indicate the sites of Ile intercalation, which sharply bends the DNA. The images shown to the right of the substrates depict the relative spatial
locations of the ﬂuorophores in the newly determined topo II/DNA structure. Lower panel. Fluorescent DNA substrate with a greater distance
separating the FRET pair. The substrate is similar to that in shown in the upper panel, but Alexa Fluor 488 is positioned three nucleotides distal to
the cleavage site, and Alexa Fluor 546 is the acceptor.
Nucleic AcidsResearch, 2009, Vol.37,No. 3 717DNA, an increased FRET eﬃciency is predicted to occur
upon topo II binding DNA. However, Smiley et al. did
not observe an increase in FRET accompanying topo II
binding with the ﬂuorescent DNA substrate (31). To help
explain this phenomenon, we examined the position of
the ﬂuorophores relative to the topo II/DNA structure.
Inspection of the complex reveals that Alexa Fluor 488
and Alexa Fluor 555 ﬂank the two DNA bases adjacent
to the sites of Ile intercalation. Each ﬂuorophore is posi-
tioned at the base of the ‘U’, near the respective Ile resi-
due, and on the second nucleotide that begins to bend
upward forming the arms of the ‘U’ (Figure 5B). Being
located at the base of the ‘U’ causes their relative spatial
positions to be less aﬀected by DNA bending than if they
were situated further apart, closer to the ends of the ‘U’
arms. Furthermore, inspection of the complex shows that
Alexa Fluor 488 and Alexa Fluor 555 are situated on
opposite sides of the DNA helix, instead of on the same
face as in the DNA-free substrate (Figure 5A). This posi-
tioning helps explain why FRET does not increase upon
topo II binding DNA. The distance between donor and
acceptor ﬂuorophores was estimated by hand-modeling a
linker arm between the nucleotide base and ﬂuorophore.
From these coarse estimates, possible distances between
donor and acceptor pairs ranged from  55A ˚ to  68A ˚ .
The estimated distances are within the range of distances
calculated from FRET measurements. FRET values sug-
gest that the ﬂuorophores are  51A ˚ apart in the closed
DNA gate and  72A ˚ apart in the open DNA gate.
Because of the uncertainty in the locations of the ﬂuoro-
phores when DNA is bound to topo II, it is plausible that
the apparent  21A ˚ gate opening is a combination of both
topo II-induced DNA distortion and partial DNA gate
opening.
Experiments with the ﬂuorophores positioned further
apart should result in a FRET increase upon topo II bind-
ing DNA, since enzyme binding bends the ends of the
DNA toward one another. Consistent with this prediction,
our experiments show that the FRET eﬃciency of such an
alternate DNA substrate indeed increases upon topo II
binding to DNA. In the new substrate, the FRET pair
(Alexa Fluor 488/Alexa Fluor 546) ﬂanks the two sites
of Ile intercalation, with Alexa Fluor 488 now located
three nucleotides distal to the respective Ile, further up
the arms of the ‘U’ (proximal to the 30-end) (Figure 5B).
The distance between the attached FRET pair is expected
to become closer by  6A ˚ upon topo II binding the sub-
strate. Initial results demonstrate that topo II increases
the FRET eﬃciency of this substrate by  15%, consistent
with this distance change (unpublished data). Additional
experiments with this and related substrates should further
elucidate the molecular motions associated with the
topo II DNA gate.
Roleof T-segment in gateopening
Previous biochemical studies suggest that a T-segment is
required for topo II-mediated G-segment cleavage (37),
while more recent work suggests that topo II is competent
to cleave DNA in the absence of a T-segment (38). The
smFRET experiments were conducted in the absence of a
T-segment, and therefore suggest that the topo II DNA
gate can open and close without the presence of a second
DNA strand. However, other biochemical investigations
show that a topo II mutant incapable of cleaving DNA
cannot trap a T-segment upon AMPPNP-induced clamp-
ing of the N-gate (2,52), supporting the suggestion from
the structural studies that the cavity of the N-gate is too
small to accommodate duplex DNA (21,53). While the
inability of the mutant enzyme to trap a T-segment is
consistent with requisite opening of the DNA gate upon
T-segment capture, it does not necessarily preclude gate
opening in the absence of a T-segment. The possibility
exists that the T-segment assists with opening the DNA
gate, although ATP alone may be suﬃcient for complete
gate opening in its absence. It is also possible that the
FRET decrease is due to the combined eﬀects of partial
gate opening in the absence of a T-segment and structural
rearrangement of the G-segment. Furthermore, the
dynamics of DNA gate opening/closing may be altered
in the presence of a T-segment, which has been proposed
to aﬀect the DNA gate equilibrium by forcing the DNA
gate closed after its passage through the G-segment
(52,53). Additional experiments are clearly required to
further address the role of the T-segment in the topo II
catalytic cycle.
CONCLUSION
The smFRET studies provide a direct observation of
the conformational changes at the topo II DNA gate.
Furthermore, recent structural studies have oﬀered the
ﬁrst picture of the topo II/DNA complex, allowing a
more in-depth understanding of how topo II interacts
with DNA. The combination of these studies has further
advanced elucidation of the topo II mechanism, while at
the same time stimulating additional questions about
how the enzyme works. For example, how far can the
DNA gate open without a T-segment, and how much of
the FRET decrease is due to topo II-induced structural
rearrangement of the G-segment? Will the presence of a
T-segment aﬀect the DNA gate dynamics and equilib-
rium? Future smFRET studies with diﬀerent substrates
and better time resolution will help address these ques-
tions. Additional structures of topo II/DNA complexes
are also needed to advance our knowledge of the complex
movements at the topo II DNA gate.
ACKNOWLEDGEMENTS
We are grateful to Dr Derike Smiley for conducting initial
single molecule experiments. We also thank Dr Jane
Richardson for assistance with assembling the topo II
structure. Christopher Capp and Stefanie Hartman Chen
provided helpful comments on the manuscript.
FUNDING
This work was supported by National Institutes of Health
(GM29006 to T.-s.H; GM65128 to G.G.H.). T.R.L.C. was
supported in part by a grant from the Department of
718 Nucleic Acids Research, 2009, Vol. 37,No. 3Defense Breast Cancer Research Program. Funding for
open access charge: National Institutes of Health
(GM29006).
Conﬂict of interest statement. None declared.
REFERENCES
1. Hsieh,T.-S. (1992) DNA topoisomerases. Curr. Opin. Cell Biol., 4,
396–400.
2. Wang,J.C. (1998) Moving one DNA double helix through another
by a type II DNA topoisomerase: the story of a simple molecular
machine. Quart. Rev. Biophys., 31, 107–144.
3. Wang,J.C. (2002) Cellular roles of DNA topoisomerases: a
molecular perspective. Nat. Rev. Mol. Cell Biol., 3, 430–440.
4. Wang,J.C. (1996) DNA topoisomerases. Ann. Rev. Biochem., 65,
635–692.
5. Cozzarelli,N.R. (1980) DNA topoisomerases. Cell, 22, 327–328.
6. Reece,R.J. and Maxwell,A. (1991) DNA gyrase: structure and
function. Crit. Rev. Biochem. Mol. Biol., 26, 335–375.
7. Wigley,D.B. (1995) Structure and mechanism of DNA topoisom-
erases. Ann. Rev. Biophys. Biomol. Struct., 24, 185–208.
8. Corbett,K.D. and Berger,J.M. (2004) Structure, molecular
mechanisms, and evolutionary relationships in DNA topoisom-
erases. Annu. Rev. Biophys. Biomol. Struct., 33, 95–118.
9. Champoux,J.J. (2001) DNA topoisomerases: structure, function,
and mechanism. Annu. Rev. Biochem., 70, 369–413.
10. Lindsley,J.E. and Wang,J.C. (1991) Proteolysis patterns of epitopi-
cally labeled yeast DNA topoisomerase II suggest an allosteric
transition in the enzyme induced by ATP binding. Proc. Natl Acad.
Sci. USA, 88, 10485–10489.
11. Lee,M.P. and Hsieh,T.S. (1994) Linker insertion mutagenesis of
Drosophila topoisomerase II. Probing the structure of eukaryotic
topoisomerase II. J. Mol. Biol., 235, 436–447.
12. Shiozaki,K. and Yanagida,M. (1991) A functional 125-kDa core
polypeptide of ﬁssion yeast DNA topoisomerase II. Mol. Cell Biol.,
11, 6093–6102.
13. Hu,T., Sage,H. and Hsieh,T.-S. (2002) ATPase domain of eukary-
otic DNA topoisomerase II. Inhibition of ATPase activity by
the anti-cancer drug bisdioxopiperazine and ATP/ADP-induced
dimerization. J. Biol. Chem., 277, 5944–5951.
14. Lindsley,J.E. and Wang,J.C. (1993) Study of allosteric communi-
cation between protomers by immunotagging. Nature, 361, 749–750.
15. Crenshaw,D.G. and Hsieh,T. (1993) Function of the hydrophilic
carboxyl terminus of type II DNA topoisomerase from Drosophila
melanogaster.I .In vitro studies. J. Biol. Chem., 268, 21328–21334.
16. Caron,P.R., Watt,P. and Wang,J.C. (1994) The C-terminal domain
of Saccharomyces cerevisiae DNA topoisomerase II. Mol. Cell Biol.,
14, 3197–3207.
17. Shiozaki,K. and Yanagida,M. (1992) Functional dissection of the
phosphorylated termini of ﬁssion yeast DNA topoisomerase II.
J. Cell. Biol., 119, 1023–1036.
18. Shaiu,W.L., Hu,T. and Hsieh,T.S. (1999) The hydrophilic, protease-
sensitive terminal domains of eucaryotic DNA topoisomerases have
essential intracellular functions. Paciﬁc Symposium on Biocomputing,
578–589
19. Adachi,N., Miyaike,M., Kato,S., Kanamaru,R., Koyama,H. and
Kikuchi,A. (1997) Cellular distribution of mammalian DNA
topoisomerase II is determined by its catalytically dispensable
C-terminal domain. Nuclic Acids Res., 25, 3135–3142.
20. Crenshaw,D.G. and Hsieh,T. (1993) Function of the
hydrophilic carboxyl terminus of type II DNA topoisomerase from
Drosophila melanogaster. II. In vivo studies. J. Biol. Chem., 268,
21335–21343.
21. Schoeﬄer,A.J. and Berger,J.M. (2005) Recent advances in
understanding structure-function relationships in the type II topo-
isomerase mechanism. Biochem. Soc. Trans., 33, 1465–1470.
22. Dong,K.C. and Berger,J.M. (2007) Structural basis for gate-DNA
recognition and bending by type IIA topoisomerases. Nature, 450,
1201–1205.
23. Schoeﬄer,A.J. and Berger,J.M. (2008) DNA topoisomerases:
harnessing and constraining energy to govern chromosome
topology. Quart. Rev. Biophys., 41, 41–101.
24. Classen,S., Olland,S. and Berger,J.M. (2003) Structure of the
topoisomerase II ATPase region and its mechanism of inhibition by
the chemotherapeutic agent ICRF-187. [Erratum (2003) Proc. Natl
Acad. Sci. USA, 100, 14510]. Proc. Natl Acad. Sci. USA, 100,
10629–10634.
25. Wei,H., Ruthenburg,A.J., Bechis,S.K. and Verdine,G.L. (2005)
Nucleotide-dependent domain movement in the ATPase domain of
a human type IIA DNA topoisomerase. J. Biol. Chem., 280,
37041–37047.
26. Berger,J.M., Gamblin,S.J., Harrison,S.C. and Wang,J.C. (1996)
Structure and mechanism of DNA topoisomerase II. Nature, 379,
225–232.
27. Fass,D., Bogden,C.E. and Berger,J.M. (1999) Quaternary changes
in topoisomerase II may direct orthogonal movement of two DNA
strands. Nat. Struct. Mol. Biol., 6, 322–326.
28. Roca,J., Berger,J.M., Harrison,S.C. and Wang,J.C. (1996) DNA
transport by a type II topoisomerase: Direct evidence for a two-gate
mechanism. Proc. Natl Acad. Sci. USA, 93, 4057–4062.
29. Berger,J.M. and Wang,J.C. (1996) Recent developments in DNA
topoisomerase II structure and mechanism. Curr. Opin. Struct.
Biol., 6, 84–90.
30. Roca,J. and Wang,J.C. (1992) The capture of a DNA double helix
by an ATP-dependent protein clamp: a key step in DNA transport
by type II DNA topoisomerases. Cell, 71, 833–840.
31. Smiley,R.D., Collins,T.R., Hammes,G.G. and Hsieh,T.S. (2007)
Single-molecule measurements of the opening and closing of the
DNA gate by eukaryotic topoisomerase II. Proc. Natl Acad. Sci.
USA, 104, 4840–4845.
32. Stryer,L. and Haugland,R.P. (1967) Energy transfer: a spectroscopic
ruler. Proc. Natl Acad. Sci. USA, 58, 719–726.
33. Fo ¨ rster,T. (1948) Zwischenmolekulare Energiewanderung und
Fluoreszenz. Annalen. Der. Physik., 437, 55–75.
34. Sander,M. and Hsieh,T.-S. (1983) Double strand DNA cleavage by
type II DNA topoisomerase from Drosophila melanogaster. J. Biol.
Chem., 258, 8421–8428.
35. Sander,M. and Hsieh,T.-S. (1985) Drosophila topoisomerase II
double-strand DNA cleavage: analysis of DNA sequence homology
at the cleavage site. Nucleic Acids Res., 13, 1057–1072.
36. Lund,K., Andersen,A.H., Christiansen,K., Svejstrup,J.Q. and
Westergaard,O. (1990) Minimal DNA requirement for
topoisomerase II-mediated cleavage in vitro. J. Biol. Chem., 265,
13856–13863.
37. Corbett,A.H., Zechiedrich,E.L. and Osheroﬀ,N. (1992) A role for
the passage helix in the DNA cleavage reaction of eukaryotic
topoisomerase II. A two-site model for enzyme-mediated DNA
cleavage. J. Biol. Chem., 267, 683–686.
38. Mueller-Planitz,F. and Herschlag,D. (2006) Interdomain communi-
cation in DNA topoisomerase II: DNA binding and enzyme
activation. J. Biol. Chem., 281, 23395–23404.
39. Lee,M.P., Sander,M. and Hsieh,T.-s. (1989) Nuclease protection by
Drosophila DNA topoisomerase II. J. Biol. Chem., 264,
21779–21787.
40. Thomsen,B., Bendixen,C., Lund,K., Andersen,A.H., Sorensen,B.S.
and Westergaard,O. (1990) Characterization of the interaction
between topoisomerase II and DNA by transcriptional footprinting.
J. Mol. Biol., 215, 237–244.
41. Dale,R.E., Eisinger,J. and Blumberg,W.E. (1979) The orientational
freedom of molecular probes. The orientation factor in intramole-
cular energy transfer. Biophys. J., 26, 161–193.
42. Min,W., English,B.P., Luo,G., Cherayil,B.J., Kou,S.C. and Xie,X.S.
(2005) Fluctuating enzymes: lessons from single-molecule studies.
Acc. Chem. Res., 38, 923–931.
43. Smiley,R.D., Zhuang,Z., Benkovic,S.J. and Hammes,G.G. (2006)
Single-molecule investigation of the T4 bacteriophage DNA poly-
merase holoenzyme: multiple pathways of holoenzyme formation.
Biochemistry, 45, 7990–7997.
44. Sander,M., Hsieh,T.-S., Udvardy,A. and Schedl,P. (1987) Sequence
dependence of Drosophila topoisomerase II in plasmid relaxation
and DNA binding. J. Mol. Biol., 194, 219–229.
45. Osheroﬀ,N., Shelton,E.R. and Brutlag,D.L. (1983) DNA topo-
isomerase II from Drosophila melanogaster. J. Biol. Chem., 258,
9536–9543.
46. Antikainen,N.M., Smiley,R.D., Benkovic,S.J. and Hammes,G.G.
(2005) Conformation coupled enzyme catalysis: single-molecule and
Nucleic AcidsResearch, 2009, Vol.37,No. 3 719transient kinetics investigation of dihydrofolate reductase.
Biochemistry, 44, 16835–16843.
47. Lindsley,J.E. and Wang,J.C. (1993) On the coupling between ATP
usage and DNA transport by yeast DNA topoisomerase II. J. Biol.
Chem., 268, 8096–8104.
48. Strick,T.R., Croquette,V. and Bensimon,D. (2000) Single-molecule
analysis of DNA uncoiling by a type II topoisomerase. Nature, 404,
901–904.
49. Liu,L.F. (1989) DNA topoisomerase poisons as antitumor drugs.
Ann. Rev. Biochem., 58, 351–375.
50. Wilsterman,A.M. and Osheroﬀ,N. (2003) Stabilization of eukaryotic
topoisomerase II-DNA cleavage complexes. Curr. Top. Med. Chem.,
3, 321–338.
51. Li,W. and Wang,J.C. (1997) Footprinting of yeast DNA topo-
isomerase II lysyl side chains involved in substrate binding and
interdomainal interactions. J. Biol. Chem., 272, 31190–31195.
52. Roca,J. (2004) The path of the DNA along the dimer interface
of topoisomerase II. J. Biol. Chem., 279, 25783–25788.
53. Wang,J.C. (2007) Unlocking and opening a DNA gate. Proc. Natl
Acad. Sci. USA, 104, 4773–4774.
720 Nucleic Acids Research, 2009, Vol. 37,No. 3